Disclosed is the use of the reactive components of the inverse electron-demand Diels Alder reaction for chemical masking and unmasking in vitro. This can be applied in complex chemical reactions and, particularly in the synthesis of biomolecules, e.g. on solid supports. The reactice components are a dienophile, particularly a trans-cyclooctene, and a diene, particularly a tetrazine.

Provided herein are methods for the production of glycopyrronium tosylate and glycopyrronium tosylate compositions. Also provided herein are compositions useful in the production of glycopyrronium tosylate. Additionally provided herein are glycopyrronium tosylate compositions. Glycopyrronium tosylate is useful for the treatment of, among other conditions, hyperhidrosis.

Provided herein are methods for the production of glycopyrronium tosylate and glycopyrronium tosylate compositions. Also provided herein are compositions useful in the production of glycopyrronium tosylate. Additionally provided herein are glycopyrronium tosylate compositions. Glycopyrronium tosylate is useful for the treatment of, among other conditions, hyperhidrosis.

There is provided the use of a nitro-substituted aromatic compound of formula (I), (II), (III), or (IV) and a copolymers comprising repeat units of formula (III) and/or (IV) as an electrode material as well as the use of such compound in the manufacture of an electrode. An electrode composite material and an electrode comprising this compound are also provided. When used in metal-ion batteries, preferably Li-ion batteries, the electrode of the invention has a combination of high operating voltage (e.g. >2.0 V) and high specific capacities (e.g. >300 mAh g.sup.1). To the best of the inventors' knowledge, some of them have the highest specific capacity, along N with high voltage, among organic electrode materials reported to date for application in alkali-ion batteries. (I), (II), (III), (IV).

There is provided the use of a nitro-substituted aromatic compound of formula (I), (II), (III), or (IV) and a copolymers comprising repeat units of formula (III) and/or (IV) as an electrode material as well as the use of such compound in the manufacture of an electrode. An electrode composite material and an electrode comprising this compound are also provided. When used in metal-ion batteries, preferably Li-ion batteries, the electrode of the invention has a combination of high operating voltage (e.g. >2.0 V) and high specific capacities (e.g. >300 mAh g.sup.1). To the best of the inventors' knowledge, some of them have the highest specific capacity, along N with high voltage, among organic electrode materials reported to date for application in alkali-ion batteries. (I), (II), (III), (IV).

Fluorescence quenching nitrodiarylethene analogs are useful in oligonucleotide conjugates and probes. These analogs, whose absorption spectra are substantially blue-shifted relatively to emission spectra of common fluorophores (such as fluorescein), do not need to rely on spectral overlap of quencher absorbance and fluorophore's emission for their quenching abilities. The oligonucleotide-quencher conjugates may be used in detection methods for nucleic acid targets.

Fluorescence quenching nitrodiarylethene analogs are useful in oligonucleotide conjugates and probes. These analogs, whose absorption spectra are substantially blue-shifted relatively to emission spectra of common fluorophores (such as fluorescein), do not need to rely on spectral overlap of quencher absorbance and fluorophore's emission for their quenching abilities. The oligonucleotide-quencher conjugates may be used in detection methods for nucleic acid targets.

Some embodiments of the invention include inventive catalysts (e.g., compounds of Formula (I) or (Ia)). Other embodiments include compositions comprising the inventive catalysts. Some embodiments include methods of using the inventive catalysts (e.g., in hydrofluorination of an organic compound). Further embodiments include methods for making the inventive catalysts. Additional embodiments of the invention are also discussed herein.

Some embodiments of the invention include inventive catalysts (e.g., compounds of Formula (I) or (Ia)). Other embodiments include compositions comprising the inventive catalysts. Some embodiments include methods of using the inventive catalysts (e.g., in hydrofluorination of an organic compound). Further embodiments include methods for making the inventive catalysts. Additional embodiments of the invention are also discussed herein.

The present invention relates inter alia to a compound of formula (I) wherein R.sub.1, R.sub.2 and R.sub.3, are as defined in the specification and to compositions comprising the same and to the use of the compounds and to compositions of the compounds in treatment, for example in the treatment of fibrotic diseases or interstitial lung diseases, in particular idiopathic pulmonary fibrosis.